wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46688699-E97762D1-D6B3-4F5C-8E6A-77DF1034820C
Q46688699-E97762D1-D6B3-4F5C-8E6A-77DF1034820C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46688699-E97762D1-D6B3-4F5C-8E6A-77DF1034820C
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.
P2860
Q46688699-E97762D1-D6B3-4F5C-8E6A-77DF1034820C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46688699-E97762D1-D6B3-4F5C-8E6A-77DF1034820C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6ebeb8b217d62d0e0d9ff2c9a10e318a188e3cff
P2860
Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models